PL3334707T3 - Sposób wytwarzania związku stanowiącego n-(3,5-dimetylofenylo)-n'-(2-trifluorometylofenylo)guanidynę - Google Patents

Sposób wytwarzania związku stanowiącego n-(3,5-dimetylofenylo)-n'-(2-trifluorometylofenylo)guanidynę

Info

Publication number
PL3334707T3
PL3334707T3 PL16756641T PL16756641T PL3334707T3 PL 3334707 T3 PL3334707 T3 PL 3334707T3 PL 16756641 T PL16756641 T PL 16756641T PL 16756641 T PL16756641 T PL 16756641T PL 3334707 T3 PL3334707 T3 PL 3334707T3
Authority
PL
Poland
Prior art keywords
trifluoromethylphenyl
dimethylphenyl
guanidine
compound
preparation
Prior art date
Application number
PL16756641T
Other languages
English (en)
Polish (pl)
Inventor
José AMATO
Original Assignee
Chemo Research, S.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Research, S.L. filed Critical Chemo Research, S.L.
Publication of PL3334707T3 publication Critical patent/PL3334707T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/02—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of guanidine from cyanamide, calcium cyanamide or dicyandiamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/06—Purification or separation of guanidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/08—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL16756641T 2015-08-11 2016-08-10 Sposób wytwarzania związku stanowiącego n-(3,5-dimetylofenylo)-n'-(2-trifluorometylofenylo)guanidynę PL3334707T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP15382424 2015-08-11
ARP150102582A AR101498A1 (es) 2015-08-11 2015-08-11 Procedimiento para la preparación del compuesto n-(3,5-dimetilfenil)-n-(2-trifluorometilfenil)guanidina y su forma cristalina a
EP16756641.3A EP3334707B1 (en) 2015-08-11 2016-08-10 A process for the preparation of the compound n-(3,5-dimethylphenyl)-n'-(2-trifluoromethylphenyl) guanidine
PCT/EP2016/069033 WO2017025560A1 (en) 2015-08-11 2016-08-10 A process for the preparation of the compound n-(3,5-dimethylphenyl)-n'-(2-trifluoromethylphenyl) guanidine

Publications (1)

Publication Number Publication Date
PL3334707T3 true PL3334707T3 (pl) 2020-05-18

Family

ID=56799434

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16756641T PL3334707T3 (pl) 2015-08-11 2016-08-10 Sposób wytwarzania związku stanowiącego n-(3,5-dimetylofenylo)-n'-(2-trifluorometylofenylo)guanidynę

Country Status (21)

Country Link
US (1) US10343984B2 (cg-RX-API-DMAC10.html)
EP (1) EP3334707B1 (cg-RX-API-DMAC10.html)
JP (1) JP6748188B2 (cg-RX-API-DMAC10.html)
CN (1) CN107922322B (cg-RX-API-DMAC10.html)
AR (1) AR101498A1 (cg-RX-API-DMAC10.html)
BR (1) BR112018002614B1 (cg-RX-API-DMAC10.html)
CA (1) CA2994781A1 (cg-RX-API-DMAC10.html)
CY (1) CY1122481T1 (cg-RX-API-DMAC10.html)
DK (1) DK3334707T3 (cg-RX-API-DMAC10.html)
ES (1) ES2756580T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20192301T1 (cg-RX-API-DMAC10.html)
HU (1) HUE046959T2 (cg-RX-API-DMAC10.html)
LT (1) LT3334707T (cg-RX-API-DMAC10.html)
MX (1) MX383481B (cg-RX-API-DMAC10.html)
PL (1) PL3334707T3 (cg-RX-API-DMAC10.html)
PT (1) PT3334707T (cg-RX-API-DMAC10.html)
RS (1) RS59759B1 (cg-RX-API-DMAC10.html)
RU (1) RU2737430C2 (cg-RX-API-DMAC10.html)
SI (1) SI3334707T1 (cg-RX-API-DMAC10.html)
SM (1) SMT201900747T1 (cg-RX-API-DMAC10.html)
WO (1) WO2017025560A1 (cg-RX-API-DMAC10.html)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN172842B (cg-RX-API-DMAC10.html) * 1990-05-17 1993-12-11 Boots Pharmaceuticals Limited
WO1997045111A1 (en) * 1996-05-24 1997-12-04 Neurosearch A/S Phenyl derivatives useful as blockers of chloride channels
WO2010051129A2 (en) * 2008-10-03 2010-05-06 The United States Of America, As Represented By The Secretary Of The Army, On Behalf Of U.S. Army Medical Research And Materiel Command New imidazolidinedione derivatives as antimalarial agents, preparation thereof, and methods of use
RU2612533C2 (ru) 2011-10-11 2017-03-09 Универсидад Насьональ Де Килмес Производные фенилгуанидина

Also Published As

Publication number Publication date
BR112018002614A2 (cg-RX-API-DMAC10.html) 2018-10-02
JP6748188B2 (ja) 2020-08-26
CN107922322B (zh) 2023-11-03
MX383481B (es) 2025-03-14
HK1256253A1 (en) 2019-09-20
LT3334707T (lt) 2020-01-27
DK3334707T3 (da) 2020-01-06
RU2737430C2 (ru) 2020-11-30
US10343984B2 (en) 2019-07-09
PT3334707T (pt) 2020-01-14
SMT201900747T1 (it) 2020-03-13
RU2018107840A3 (cg-RX-API-DMAC10.html) 2019-12-18
US20180244608A1 (en) 2018-08-30
HUE046959T2 (hu) 2020-04-28
SI3334707T1 (sl) 2020-03-31
CY1122481T1 (el) 2021-01-27
AR101498A1 (es) 2016-12-21
WO2017025560A1 (en) 2017-02-16
MX2018001548A (es) 2018-06-22
RU2018107840A (ru) 2019-09-12
JP2018525393A (ja) 2018-09-06
HRP20192301T1 (hr) 2020-03-20
EP3334707B1 (en) 2019-10-09
CA2994781A1 (en) 2017-02-16
RS59759B1 (sr) 2020-02-28
EP3334707A1 (en) 2018-06-20
CN107922322A (zh) 2018-04-17
ES2756580T3 (es) 2020-04-27
BR112018002614B1 (pt) 2023-04-11

Similar Documents

Publication Publication Date Title
IL266611A (en) Converted N-(3-fluorophenyl)-pyrrolidine substances, process for their preparation and medical use thereof
IL250239A0 (en) Method for the preparation of (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carbox-amide and the purification thereof for use as an active pharmaceutical ingredient
IL263911B (en) Synthesis of n-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines
SI3097098T1 (sl) Postopek za pripravo N-((3-aminooksetana-3-il)metil)-2-(1,1-diokso- 3,5-dihidro-1,4-benzotiazepin-4-il)-6-metil-kinazolin-4-amina
IL256191B (en) New aminoacid derivatives, a process for their preparation and pharmaceutical compositions containing them
ZA201708417B (en) (s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
IL267899A (en) 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as magl inhibitors
CR20170315A (es) Inhibridores bace 1 selectivos
DK3497081T3 (da) Fremgangsmåde til fremstilling af 4-ammonium-2,2,6,6-tetraalkylpiperidinylsalte
AP2016009387A0 (en) Agrochemical composition comprising a n, n'-disubstituted (thio)urea for the improvement of crop productivity
PL3470400T3 (pl) Krystaliczne postacie ozanimodu i chlorowodorku ozanimodu oraz sposoby ich otrzymywania
HUE052833T2 (hu) Eljárás 2,5-furándikarbonsav (FDCA) elõállítására
MY183123A (en) Synthesis of copanlisib and its di hydrochloride salt
IL260665B (en) Improved process for the preparation of osimertinib (azd9291) or its salt and "azd9291 aniline" or its salt
PL3317272T3 (pl) Chwastobójczo skuteczne pochodne N-(1,3,4-oksadiazol-2-ilo)arylokarboksyamidowe
ZA202004349B (en) Fluoralkenyl compounds, process for preparation and use thereof
PL3285755T3 (pl) Chlorowodorek kreatyny do leczenia choroby Huntingtona
DK3456712T3 (da) Hidtil ukendte 2,4,6-trisubstitueret S-triazinforbindelse, fremgangsmåde til fremstilling deraf og anvendelse deraf
ZA201907272B (en) N-(4-pyridyl)nicotinamide compound or salt thereof
FI3878444T3 (fi) (n-(2-((2-bentsyylifenyyli)amino)-2-oksoetyyli)-l-naftamidi) syöpälääkeaineena
LT3334707T (lt) N-(3,5-dimetilfenil)-n'-(2-trifluormetilfenilo) guanidino paruošimo būdas
IL254454B (en) Chemical synthesis methods of bivalent compounds related to pyrrole and their preparations
EP3294703A4 (en) A process for the preparation of verapamil hydrochloride
MX2021010016A (es) Modificaciones cristalinas de clorhidrato de n-(4,5-bismetansulfon il-2-metilbenzoil)guanidina y sales de n-(4,5-bismetansulfonil-2-m etilbenzoil)guanidina.
LT3564230T (lt) Pakeistas guanidino junginys